Uniting Forces in Resectable Cutaneous Squamous Cell Carcinoma: The Multidisciplinary Playbook

NOV 9, 202661 MIN

Description

Please visit answersincme.com/860/MED-ONC-03731-replay1 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Sunandana Chandra, MD, MS; Vishal A. Patel, MD; Vernon K. Sondak, MD; and Jessica Kalen, MD, FAAD. In this activity, experts in skin cancer discuss the current use of immunotherapy-based treatment approaches in resectable cutaneous squamous cell carcinoma (CSCC), with a focus on the role of dermatologists in the multidisciplinary team. Upon completion of this activity, participants should be better able to: Outline guideline-recommended clinical approaches for the management of patients with early-stage CSCC; Specify key real-world considerations that influence the appropriate use of neoadjuvant and adjuvant immunotherapy in resectable CSCC, within the context of multidisciplinary care; and Formulate a collaborative care plan that defines the roles and responsibilities of multidisciplinary team members to optimize outcomes for patients with resectable CSCC who are candidates for neoadjuvant and/or adjuvant immunotherapy. This activity is intended for US healthcare professionals only.